Acalabrutinib and Rituximab for the Treatment of Previously Untreated Mantle Cell Lymphoma
Clinical trial NCT04765111 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04765111
- Sponsor
- M.D. Anderson Cancer Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-30
- Primary completion
- 2028-08-30
- Enrollment
- 53
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.